AMP2
Live / Applied — Opposition pending (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 08 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98843894
- Mark type
- Stylized text
- Filed
- 08 Nov 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- AARON D. HENDELMAN
Goods and services
- Class 001 — Chemicals: targetable bone morphogenetic proteins for use as an inducer of regenerative bone growth other than for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Therapeutic proteins in the nature of bone morphogenetic proteins for use as a bone growth media for medical purposes, namely, the manufacture of implantable medical devices; Therapeutic proteins in the nature of bone morphogenetic proteins for medical use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; pharmaceutical and medicinal preparations and substances for the treatment and prevention of bone and tissue diseases and disorders, musculoskeletal diseases and disorders, blood vessel diseases and damage, craniomaxillofacial diseases and damage, skin diseases and damage, bone and joint injuries, and cancer, namely, therapeutic proteins used for vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; human allograft bone and tissue
- Class 010 — Medical apparatus: Implantable scaffolds comprising synthetic materials for maintaining tissue contour; implants consisting of synthetic materials; synthetic bone grafts; implants comprising natural, non-living materials; implantable scaffolds comprising synthetic materials, namely, fusion cages for spinal surgery and expandable spinal implants; bone void fillers comprised of synthetic materials; bone regeneration matrices being artificial biomaterials for augmentation of bone for medical purposes; soft tissue regeneration matrices being surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; implantable medical devices to regenerate, repair, or treat soft tissue and bone; medical and surgical devices, apparatus, and instruments for use in bone and joint surgery, regeneration, reconstruction, and augmentation; artificial biomaterials for augmentation of bone for medical purposes, namely, synthetic materials for use in bone and joint surgery, bone regeneration, and bone reconstruction; bone implants composed of synthetic materials; implantable synthetic materials for surgical repair, regeneration, reconstruction, and augmentation of human tissue; artificial biomaterials for augmentation of tissue for medical purposes, namely, non-living tissue substitutes for use in human tissue repair, regeneration, and reconstruction; synthetic implantable medical devices for the regeneration of bone defects
- Class 042 — Scientific and technological services: Research and development in connection with protein therapies for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, and protein therapeutics; development of therapeutics, namely, pharmaceutical and medical therapies for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine; scientific research and development; research and development of medical devices, apparatus, and implants for use in vascular repair, orthopedic repair, bone repair, osteochondral repair, spinal fusion, dermal repair, soft tissue repair, extremities repair, craniomaxillofacial repair, chemotherapeutics, and sports medicine
Owner
- Theradaptive, Inc., Frederick, MD, US
- Theradaptive, Inc., Frederick, MD, US
Prosecution history
- 09 Mar 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 04 Mar 2026 — OPPOSITION INSTITUTED NO. 999999
- 06 Oct 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 08 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 08 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 12 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 May 2025 — NON-FINAL ACTION E-MAILED
- 12 May 2025 — NON-FINAL ACTION WRITTEN
- 06 May 2025 — ASSIGNED TO EXAMINER